![]() |
![]() |
BronchiolitisDefinition Bronchiolitis is an inflammation of the bronchioles (small passages in the lungs) usually caused by a viral infection. Causes, incidence, and risk factors The disease usually affects children under the age of 2, with a peak age of 3 to 6 months, and is a common, sometimes severe illness. Respiratory syncytial virus (RSV) is one common cause. Other viruses that can cause bronchiolitis include: parainfluenza, influenza, and adenovirus. The virus is transmitted from person-to-person by direct contact with nasal secretions or by airborne droplets. Although RSV generally causes only mild symptoms in an adult, it can cause a severe illness in an infant. Bronchiolitis begins as a mild upper respiratory infection that, over a period of 2 to 3 days, can develop into increasing respiratory distress with wheezing and a "tight," wheezy cough. The infant's breathing rate may increase a lot (tachypnea), and the infant may become irritable or anxious-looking. If the disease is severe enough, the infant may turn bluish (cyanotic), an indication of a critical emergency. As the effort of breathing increases, parents may see the nostrils flaring with each breath and the muscles between the ribs retracting (intercostal retractions) as the child tries to inhale air. This can be exhausting for the child, and very young infants may become so fatigued that breathing becomes difficult to maintain. Bronchiolitis is seasonal and appears more frequently in the fall and winter months. It is a very common reason for infants to be hospitalized during winter and early spring. Some children have subclinical infections, that is, few or insignificant symptoms. It is estimated that by the first year, more than half of all infants have been exposed to RSV. Risk factors include:
Symptoms
Signs and tests
Treatment Antibiotics are not effective against viral infections. Sometimes, no treatment is necessary. Supportive therapy may include oxygen, humidified air, chest clapping(postural drainage to remove secretions), rest, and clear fluids. Other medicines used in the hospital may include albuterol (a medication normally used in asthma) or steroids. In extremely ill children, antiviral medications (such as ribavirin) are sometimes used. Antiviral treatment may decrease the severity and duration of the illness. To be effective, it must be administered early in the course of the illness. Expectations (prognosis) Usually, the symptoms have resolved within a week, and difficulty breathing usually improves by the third day. The mortality rate is less than 1%. Complications
Calling your health care provider Call your health care provider immediately, or go to the emergency room if the person, child, or infant:
Prevention Most cases of bronchiolitis are not readily preventable because the viruses that cause the disorder are common in the environment. Careful attention to hand washing, especially around infants, can aid in the prevention or spread of respiratory viruses. Family members with an upper respiratory infection should be especially careful around infants. Wash hands frequently, especially before handling the child. At this date, there is no RSV vaccine available. However, there is an effective product available for infants at high risk for developing severe disease from RSV. The product is Synagis® (palivizumab).Consult your child's physician to determine whether this medication would be appropriate for your child. Illustrations
Page Content: bronchiolitis; bronchiolitis obliterans; bronchiolitis obliterans organizing pneumonia; bronchiolitis in infant; acute bronchiolitis; bronchiolitis rsv; bronchiolitis treatment; bronchiolitis obliterans pediatric; bronchiolitis pediatric; bronchiolitis pathophysiology |
![]() ![]() ![]() |